GENOME RESEARCH LIMITED
The Gibbs Building, Euston Road 215 – London – NW1 2BE
VAT: GB744495211
http://www.sanger.ac.uk
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, GENOME RESEARCH LIMITED has received € 651,526.0 for its participation in a total of 2 project(s) with a total cost of € 8,967,913.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-01 | 664918 | MRG-GRammar | bacteriology · synthetic biology · DNA · proteins · embryology | 2018-07-31 | participant | € 581,651.25 | € 3,999,661 | 3 | 7 | CORDIS ↪ |
| 2017-01-01 | 730879 | INFRAFRONTIER2020 | databases · business models · personalized medicine · genomes · microbiology | 2021-12-31 | participant | € 69,875.0 | € 4,968,252 | 1 | 29 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, GENOME RESEARCH LIMITED has received € 0.0 for its participation in a total of 1 project(s) with a total cost of € 0.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 101119927 | IMMERGE | gene therapy · immunology · mutation · personalized medicine · leukemia | 2027-12-31 | associatedPartner | € nan | € 0 | 3 | 26 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, GENOME RESEARCH LIMITED has received € 2,773,474.0 for its participation in a total of 9 project(s) with a total cost of € 116,145,645.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-12-01 | 222886 | MICROME | metabolic engineering · databases · proteins · environmental biotechnology · genomes | 2013-11-30 | participant | € 321,756.0 | € 7,527,543 | 1 | 16 | CORDIS ↪ |
| 2010-11-01 | 259949 | ESNIP 3 | databases · virology · pandemics · influenza | 2013-10-31 | participant | € 90,000.0 | € 1,205,843 | 1 | 24 | CORDIS ↪ |
| 2011-10-01 | 282510 | BLUEPRINT | autoimmune diseases · leukemia · genomes · epigenetics | 2016-09-30 | participant | € 573,766.6 | € 39,664,716 | 1 | 45 | CORDIS ↪ |
| 2010-10-01 | 257082 | EPIGENESYS | epigenetics | 2016-03-31 | participant | € 149,996.4 | € 15,952,636 | 1 | 28 | CORDIS ↪ |
| 2013-01-01 | 312325 | INFRAFRONTIER-I3 | biochemistry · mutation · physiology · functional analysis · genomes | 2016-12-31 | participant | € 889,031.09 | € 12,431,663 | 1 | 24 | CORDIS ↪ |
| 2010-01-01 | 241498 | EUROSPIN | proteins · mutation · physiology | 2014-06-30 | participant | € 452,922.52 | € 15,806,674 | 2 | 18 | CORDIS ↪ |
| 2007-11-01 | 211601 | ELIXIR | governance · agriculture | 2012-12-31 | participant | € 80,000.0 | € 5,868,924 | 1 | 33 | CORDIS ↪ |
| 2011-05-01 | 284941 | HBP | software · databases · sensors · mathematics · implants | 2012-04-30 | participant | € 80,892.0 | € 1,632,174 | 1 | 13 | CORDIS ↪ |
| 2010-11-01 | 261472 | STOPENTERICS | genetics · proteomics · infectious diseases · vaccines | 2017-12-31 | participant | € 135,111.0 | € 16,055,468 | 2 | 18 | CORDIS ↪ |